Treatment of atopic dermatitis with zafirlukast

Dermatology Online Journal

Volumn 5, Issue 2, 1999, Pages

  Zabawski Jr , Edward J ^a   Cockerell, Clay J ^a   Kahn, M A ^b   Greg, L J ^c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b NE Ohio College of Medicine ^*  (United States)

^c UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; CORTICOSTEROID; CYCLOSPORIN; CYCLOSPORIN A; TACROLIMUS; ZAFIRLUKAST;

ADULT; ANAMNESIS; ATOPIC DERMATITIS; CHILD; CLINICAL ARTICLE; DISEASE EXACERBATION; EDEMA; FEMALE; HUMAN; HYPERTENSION; LABORATORY TEST; LETTER; MALE; TREATMENT OUTCOME;

EID: 4444241654     PISSN: 10872108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (3)

1. Kelloway JS. Zafirlukast: the first leukotriene receptor antagonist available for the treatment of asthma. Ann Pharmacother. 1997;31-1012-1021.
2. Carucci JA, Washenik K, Weinstein A, Shupack J, Cohen DE. The leukotriene antagonist zafirlukast as a therapeutic agent for atopic dermatitis. Arch Dermatol 1998 Jul;134(7):785-786.
3. Calhoun WJ. Summary of clinical trials with zafirlukast. Am J Respir Crit Care Med 1998 Jun;157(6 Pt 2):S238-S245